Significant Ownership of ARMISTICE CAPITAL, LLC

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for ARMISTICE CAPITAL, LLC focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Steven Boyd - Steven Boyd - Managing Member
Manager location
New York, NY

Follow Filing Activity

Follow ARMISTICE CAPITAL, LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here

Significant Ownership of ARMISTICE CAPITAL, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARDS Aridis Pharmaceuticals, Inc. Common Stock 11% 5,096,251 0% Armistice Capital, LLC 31 Mar 2026
GNLX GENELUX Corp Common Stock, $0.001 par value per share 10% $17,737,763 4,223,277 Armistice Capital, LLC 30 Sep 2025
MGNX MACROGENICS INC Common Stock, par value $0.01 per share 10% $12,205,320 +$54,040 6,324,000 +0.44% Armistice Capital, LLC 31 Dec 2025
ESLA ESTRELLA IMMUNOPHARMA, INC. Common Stock, par value $0.0001 per share 10% $7,490,656 4,280,375 Armistice Capital, LLC 31 Mar 2026
VRCA Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value 10% $7,480,813 +$81,611 9,235,571 +1.1% Armistice Capital, LLC 31 Mar 2025
DWTX DOGWOOD THERAPEUTICS, INC. Common Stock, par value $0.0001 10% $7,053,983 3,343,120 Armistice Capital, LLC 31 Mar 2026
DTST LM FUNDING AMERICA, INC. Common Stock par value $0.001 per share 10% $6,429,912 +$4,175,161 1,498,814 +185% Armistice Capital, LLC 30 Sep 2025
CTOR Citius Oncology, Inc. Common Stock 10% $6,044,946 +$793,983 9,299,917 +15% Armistice Capital, LLC 31 Mar 2026
ASMB EKSO BIONICS HOLDINGS, INC. Common Stock, $0.001 par value per share 10% $5,252,553 289,876 Armistice Capital, LLC 30 Jun 2025
NVRO Sadot Group Inc. Common Stock, $0.0001 par value 10% $2,787,050 689,642 Armistice Capital, LLC 30 Jun 2025
IINN INSPIRA TECHNOLOGIES OXY B.H.N. LTD. Ordinary Shares, no par value 10% $1,939,696 4,343,252 Armistice Capital, LLC 31 Mar 2026
MKZR MacKenzie Realty Capital, Inc. Common Stock, $0.0001 par value per share 10% $1,815,857 1,579,006 Armistice Capital, LLC 31 Mar 2025
LICYF Li-Cycle Holdings Corp. Common shares, without par value 10% $1,370,132 4,567,108 Armistice Capital, LLC 31 Mar 2025
EKSO EKSO BIONICS HOLDINGS, INC. Common Stock, $0.001 par value per share 10% $1,207,683 +$300,925 2,996,732 +33% Armistice Capital, LLC 31 Mar 2025
IMNN Imunon, Inc. Common stock, par value $0.01 per share 10% $1,189,718 349,917 Armistice Capital, LLC 31 Dec 2025
VSEE VSee Health, Inc. Common Stock, par value $0.0001 per share 10% $1,166,734 +$713,300 4,861,392 +157% Armistice Capital, LLC 31 Mar 2026
BITF BELLICUM PHARMACEUTICALS INC Common Stock 10% $1,153,951 1,078,459 Armistice Capital, LLC 30 Jun 2025
SQFT Presidio Property Trust, Inc. Series A Common Stock, $0.01 par value per share 10% $1,021,100 +$529,359 1,570,923 +108% Armistice Capital, LLC 31 Mar 2025
MNTS Momentus Inc. Class A common stock 10% $941,801 +$604,420 500,958 +179% Armistice Capital, LLC 31 Mar 2025
IVF INVO Fertility, Inc. Common Stock 10% $850,181 602,965 Armistice Capital, LLC 31 Dec 2025
DRMA Dermata Therapeutics, Inc. Common Stock, par value $0.0001 per share 10% $820,109 +$607,264 1,065,076 +285% Armistice Capital, LLC 31 Mar 2025
BCLI Brainstorm Cell Therapeutics Inc. Common Stock, $0.00005 par value 10% $789,250 +$459,747 717,500 +140% Armistice Capital, LLC 31 Mar 2025
CLDI CALIDI BIOTHERAPEUTICS, INC. Common stock, par value $0.0001 per share 10% $655,922 -$1,326,278 1,111,732 -67% Armistice Capital, LLC 31 Mar 2026
OLB THE OLB GROUP, INC. Common Stock, $0.0001 par value 10% $610,713 1,387,983 Armistice Capital, LLC 31 Mar 2026
CERO CERO THERAPEUTICS HOLDINGS, INC. Common Stock, par value $0.0001 per share 10% $555,321 584,548 Armistice Capital, LLC 31 Mar 2025
ALBT AVALON GLOBOCARE CORP. Common Stock, par value $0.0001 per share 10% $382,924 890,521 Armistice Capital, LLC 31 Mar 2026
EDBL Edible Garden AG Inc Common Stock, par value $0.0001 per share 10% $339,122 1,994,837 Armistice Capital, LLC 31 Dec 2024
PALI PALISADE BIO, INC. Common Stock, $0.01 par value 10% $335,053 +$132,407 471,906 +65% Armistice Capital, LLC 31 Mar 2025
IVP INSPIRE VETERINARY PARTNERS, INC. Class A Common Stock, par value $0.0001 per share 10% $327,596 212,725 Armistice Capital, LLC 31 Mar 2025
IPDN Professional Diversity Network, Inc. Common Stock, $0.01 par value per share 10% $320,204 1,334,182 Armistice Capital, LLC 31 Dec 2024
IVF INVO FERTILITY, INC. Common Stock, $0.0001 par value 10% $304,681 371,562 Armistice Capital, LLC 31 Mar 2026
SNAX STRYVE FOODS, INC. Class A Common Stock 10% $297,814 397,085 0% Armistice Capital, LLC 31 Mar 2026
ARTL ARTELO BIOSCIENCES, INC. Common Stock, par value $0.001 per share 10% $282,988 235,823 Armistice Capital, LLC 31 Mar 2026
EDBL Edible Garden AG Inc Common Stock, par value $0.0001 per share 10% $277,617 +$239,134 544,348 +621% Armistice Capital, LLC 31 Dec 2025
AEMD AETHLON MEDICAL INC Common stock, par value $0.0001 per share 10% $254,333 84,496 Armistice Capital, LLC 31 Dec 2025
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S 10% $242,921 934,312 Armistice Capital, LLC 31 Dec 2024
SXTP 60 DEGREES PHARMACEUTICALS, INC. Common Stock, par value $0.0001 10% $214,590 476,866 Armistice Capital, LLC 31 Dec 2024
IMNN Imunon, Inc. Common stock, par value $0.01 per share 10% $198,359 396,718 Armistice Capital, LLC 31 Mar 2026
BJDX Bluejay Diagnostics, Inc. Common Stock, par value $0.0001 per share 10% $147,540 194,132 Armistice Capital, LLC 31 Dec 2025
SHPH Shuttle Pharmaceuticals Holdings, Inc. Common stock, par value $0.00001 10% $128,944 +$40,188 444,635 +45% Armistice Capital, LLC 31 Mar 2025
NAOV NanoVibronix, Inc. Common stock, par value $0.001 per share 10% $125,742 349,284 Armistice Capital, LLC 31 Dec 2024
BDRX Biodexa Pharmaceuticals Plc American Depositary Shares, each representing four hundred ordinary shares 10% $116,150 -$59,026 187,975 -34% Armistice Capital, LLC 31 Mar 2026
GOVX GEOVAX LABS, INC. Common Stock $0.001 par value 10% $49,496 -$405,357 291,155 -89% Armistice Capital, LLC 31 Mar 2026
HSDT HELIUS MEDICAL TECHNOLOGIES, INC. Class A Common Stock, $0.001 par value per share 10% 871,134 Armistice Capital, LLC 31 Mar 2025
CRIS CURIS INC Common Stock, Par Value $0.01 per share 10% 1,287,337 Armistice Capital, LLC 30 Jun 2025
LICY Li-Cycle Holdings Corp. Common Stock 10% 4,569,327 Armistice Capital, LLC 31 Mar 2026
LMFA LM FUNDING AMERICA, INC. Common Stock par value $0.001 per share 10% 1,661,395 Armistice Capital, LLC 31 Mar 2026
INBS INTELLIGENT BIO SOLUTIONS INC. Common Stock, $0.01 par value 10% 163,571 Armistice Capital, LLC 31 Mar 2026
RMTI TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 10% $7,544,600 8,876,000 Armistice Capital, LLC 30 Jun 2025
RANI TREACE MEDICAL CONCEPTS, INC. Common stock, $0.001 par value 9.9% $4,131,600 6,260,000 Armistice Capital, LLC 30 Jun 2025
KYNB FIBROGEN INC Common Stock, $0.01 par value 9.9% $3,508,000 +$192,940 400,000 +5.8% Armistice Capital, LLC 31 Dec 2025
FGEN KYNTRA BIO, INC. Common Stock, $0.01 par value 9.9% $124,000 -$2,511,000 400,000 -95% Armistice Capital, LLC 31 Mar 2026
IRWD IRONWOOD PHARMACEUTICALS INC Class A common stock, $0.001 par value 9.8% $82,368,500 +$11,950,500 16,025,000 +17% Armistice Capital, LLC 31 Dec 2025
TMCI Treace Medical Concepts, Inc. Common stock, $0.001 par value 9.8% $12,791,640 6,364,000 0% Armistice Capital, LLC 31 Mar 2026
SGMO SANGAMO THERAPEUTICS, INC. Common Stock, $0.01 par value per share 9.8% $10,504,017 40,400,067 Armistice Capital, LLC 31 Mar 2026
BLCM GEOVAX LABS, INC. Common Stock $0.001 par value 9.5% 2,675,610 Armistice Capital, LLC 30 Jun 2025
DYNT MACROGENICS, INC. Common Stock, par value $0.01 per share 9.5% $781,560 +$6,760 6,012,000 +0.87% Armistice Capital, LLC 31 Mar 2026
CYTH IRONWOOD PHARMACEUTICALS, INC. Class A common stock, $0.001 par value 9.2% $8,747,799 -$653,116 15,028,000 -6.9% Armistice Capital, LLC 31 Mar 2026
CYCC Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 9.2% $7,453,418 +$7,200,909 24,844,725 +2852% Armistice Capital, LLC 31 Mar 2025
SCLX Voyager Therapeutics, Inc. Common Stock, $0.001 par value 8.6% $31,008,000 4,800,000 Armistice Capital, LLC 30 Jun 2025
BCTX FIBROGEN INC Common Stock, $0.01 par value 8.3% $678,720 336,000 Armistice Capital, LLC 30 Jun 2025
VVOS Vivos Therapeutics, Inc. Common Stock, par value $0.0001 per share 8.3% $1,339,031 1,115,859 Armistice Capital, LLC 31 Mar 2026
WLDS Wearable Devices Ltd. Ordinary Shares 8% $179,987 -$303,471 230,752 -63% Armistice Capital, LLC 31 Mar 2026
REVB REVELATION BIOSCIENCES, INC. Common stock, par value $0.001 per share 7.8% $168,085 +$18,153 323,241 +12% Armistice Capital, LLC 31 Mar 2026
RKDA Arcadia Biosciences, Inc. Common 7.8% 159,390 Armistice Capital, LLC 31 Mar 2026
AXDX Accelerate Diagnostics, Inc Common Stock, $0.001 par value per share 7.4% $995,990 -$105,350 1,879,227 -9.6% Armistice Capital, LLC 31 Mar 2025
DNMRQ Kura Oncology, Inc. Common Stock, par value $0.0001 per share 7.1% $1,116,000 6,200,000 Armistice Capital, LLC 30 Jun 2025
NUWE Nuwellis, Inc. Common Stock, par value $0.0001 per share 7.1% $232,209 1,055,496 Armistice Capital, LLC 31 Mar 2026
BTAI BioXcel Therapeutics, Inc. Common Stock, par value $0.001 7% $324,713 1,910,076 Armistice Capital, LLC 31 Mar 2026
STKH Steakholder Foods Ltd. American Depositary Shares, each representing ten ordinary shares, no par value per share 7% $199,880 -$35,731 293,941 -15% Armistice Capital, LLC 31 Mar 2025
RIGL RIGEL PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share 6.9% $36,774,400 -$6,780,280 1,280,000 -16% Armistice Capital, LLC 31 Mar 2026
PTCT PTC THERAPEUTICS, INC. Common Stock, $0.001 par value per share 6.9% $269,133,425 -$46,705,135 5,434,843 -15% Armistice Capital, LLC 31 Mar 2025
BCYC Bicycle Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share 6.8% $16,922,040 +$806,760 3,398,000 +5% Armistice Capital, LLC 31 Mar 2026
GROM ORTHOFIX MEDICAL INC. Common stock, $0.10 par value per share 6.7% 2,700,000 -9.3% Armistice Capital, LLC 31 Mar 2026
OFIX Orthofix Medical Inc. Common stock, $0.10 par value per share 6.7% $40,382,000 +$6,283,000 2,648,000 +18% Armistice Capital, LLC 31 Dec 2025
STAA STAAR SURGICAL CO Common 6.1% $53,640,000 3,000,000 Armistice Capital, LLC 31 Mar 2025
ANGO Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share 6% $17,880,240 1,624,000 0% Armistice Capital, LLC 31 Dec 2025
AUTL Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, par value $0.000042 per share 5.9% $23,226,000 -$2,499,000 15,800,000 -9.7% Armistice Capital, LLC 31 Mar 2026
VYGR Voyager Therapeutics, Inc. Common Stock, $0.001 par value 5.9% $13,510,000 -$1,930,000 3,500,000 -12% Armistice Capital, LLC 31 Mar 2026
FEAM 5E Advanced Materials, Inc. Common Stock, $0.01 par value 5.8% $1,081,832 4,006,784 Armistice Capital, LLC 31 Dec 2024
ASNS ACTELIS NETWORKS INC Common Stock, $0.0001 par value per share 5.8% $333,052 901,603 Armistice Capital, LLC 30 Sep 2025
GLBS Globus Maritime Limited Common Stock, par value $0.004 per share ("Shares") 5.5% $1,992,000 1,200,000 0% Armistice Capital, LLC 31 Dec 2025
TVTX TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 5.3% $150,350,702 +$34,799,248 4,897,417 +30% Armistice Capital, LLC 31 Mar 2026
VSTM Verastem, Inc. Common stock, $0.0001 par value per share 5.2% $25,026,400 +$5,755,200 4,592,000 +30% Armistice Capital, LLC 31 Mar 2026
CKPT CHECKPOINT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 5% $17,886,545 -$3,500,879 4,362,572 -16% Armistice Capital, LLC 31 Mar 2025
ELDN ELEDON PHARMACEUTICALS, INC. Common Stock, $0.001 par value 5% $10,259,798 3,137,553 Armistice Capital, LLC 31 Dec 2024
IKT INHIBIKASE THERAPEUTICS, INC. Common Stock, $0.001 par value 5% $7,975,554 3,529,006 Armistice Capital, LLC 31 Dec 2024
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S 5% $7,049,313 1,081,183 Armistice Capital, LLC 31 Mar 2025
NEUP Neuphoria Therapeutics Inc. Common Stock 5% $5,365,401 1,033,796 Armistice Capital, LLC 31 Dec 2024
FEAM 5E Advanced Materials, Inc. Common Stock, $0.01 par value 5% $5,080,987 1,083,366 Armistice Capital, LLC 31 Mar 2025
SNTI Senti Biosciences, Inc. Class A Common Stock, par value $0.0001 per share 5% $4,564,204 +$2,865,052 1,439,812 +169% Armistice Capital, LLC 31 Mar 2025
CBUS Cibus, Inc. Class A Common Stock, $0.0001 par value per share 5% $3,963,236 +$924,356 2,540,536 +30% Armistice Capital, LLC 30 Jun 2025
VRCA Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value 5% $3,649,153 -$1,656,149 439,657 -31% Armistice Capital, LLC 31 Dec 2025
IDAI T Stamp Inc. Class A Common Stock, $0.01 par value per share 5% $2,935,544 1,397,878 Armistice Capital, LLC 31 Dec 2024
WKSP Worksport Ltd Common Stock 5% $2,895,695 1,729,909 Armistice Capital, LLC 31 Dec 2024
LMFA Rani Therapeutics Holdings, Inc. Common Stock 5% $2,865,831 -$2,046,803 2,515,652 -42% Armistice Capital, LLC 30 Sep 2025
MDCX Medicus Pharma Ltd. Common shares, no par value 5% $2,835,244 -$1,000,736 935,724 -26% Armistice Capital, LLC 30 Jun 2025
SPCB SuperCom Ltd Ordinary Shares, NIS 50 Par Value 5% $2,266,376 -$2,380,224 215,435 -51% Armistice Capital, LLC 30 Jun 2025
ITRM Iterum Therapeutics plc Ordinary Shares, $0.01 par value per share 5% $1,820,899 1,445,158 Armistice Capital, LLC 31 Dec 2024
ASTI Ascent Solar Technologies, Inc. Common Stock, par value $0.0001 per share 5% $1,803,910 +$402,215 496,945 +29% Armistice Capital, LLC 31 Mar 2026

Schedules 13D/G Reported by ARMISTICE CAPITAL, LLC:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .